Aspen Pharmacare Holdings Limited
APNHF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $56,895,181 | $98,345,831 | $76,860,299 | $60,408,683 |
| - Cash | $6,409,000 | $12,337,000 | $10,912,000 | $6,183,000 |
| + Debt | $36,120,000 | $36,456,000 | $29,282,000 | $22,247,000 |
| Enterprise Value | $86,606,181 | $122,464,831 | $95,230,299 | $76,472,683 |
| Revenue | $43,363,000 | $44,706,000 | $40,709,000 | $38,606,000 |
| % Growth | -3% | 9.8% | 5.4% | – |
| Gross Profit | $19,129,000 | $19,454,000 | $18,408,000 | $18,306,000 |
| % Margin | 44.1% | 43.5% | 45.2% | 47.4% |
| EBITDA | $2,161,000 | $9,914,000 | $9,667,000 | $10,612,000 |
| % Margin | 5% | 22.2% | 23.7% | 27.5% |
| Net Income | -$1,083,000 | $4,404,000 | $5,228,000 | $6,488,000 |
| % Margin | -2.5% | 9.9% | 12.8% | 16.8% |
| EPS Diluted | -2.44 | 9.91 | 11.77 | 14.32 |
| % Growth | -124.6% | -15.8% | -17.8% | – |
| Operating Cash Flow | $5,159,000 | $6,225,000 | $5,520,000 | $5,374,000 |
| Capital Expenditures | -$5,055,000 | -$5,535,000 | -$3,181,000 | -$2,697,000 |
| Free Cash Flow | $104,000 | $690,000 | $2,339,000 | $2,677,000 |